IP Library Assignment 068906/0747
Patent Assignment
Reel/Frame 068906/0747

Change of Name

Recorded: 2024-09-10 Pages: 5
Assignor
LABORATORIOS LESVI, S.L.
Executed: 2023-02-27
Assignee
NEURAXPHARM PHARMACEUTICALS, S.L.
AVDA. BARCELONA 69, SANT JOAN DESPÍ, 08970, SPAIN
Covered Properties (2)
Oral Formulation of Anhydrous Olanzapine Form I
Patent: 8,962,018 →
Application: 12/159,030 →
Publication: US 2008/0311203
Orodispersible Tablets
Patent: 9,623,010 →
Application: 12/680,296 →
Publication: US 2010/0297031
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 10, 2008
From: DIEZ MARTIN, IGNACIO; UBEDA PEREZ, CARMEN; PABLO ALBA, PABLO
To: LABORATORIOS LESVI, S.L.
Reel/Frame 021664/0112 →
Assignment of Assignor's Interest Jul 28, 2010
From: UBEDA PEREZ, CARMEN; DIEZ MARTIN, IGNACIO; PABLO ALBA, PABLO
To: LABORATORIOS LESVI, S.L.
Reel/Frame 024750/0280 →